Medication adherence/persistence among patients with active multiple sclerosis in Finland
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Medication adherence/persistence among patients with active multiple sclerosis in Finland
Authors
Keywords
-
Journal
ACTA NEUROLOGICA SCANDINAVICA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-20
DOI
10.1111/ane.13301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies
- (2019) Pierre Duquette et al. PLoS One
- Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees
- (2019) Krish Patel et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
- (2019) Ramón Morillo Verdugo et al. Patient Preference and Adherence
- Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
- (2019) Phuong N. Pham et al. BMC Cardiovascular Disorders
- Multiple sclerosis in Finland 2018—Data from the national register
- (2019) Sini M. Laakso et al. ACTA NEUROLOGICA SCANDINAVICA
- Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
- (2019) Somratai Vadcharavivad et al. DRUGS
- Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs
- (2019) Carlyne M. Averell et al. JOURNAL OF ASTHMA
- NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters?
- (2019) Jongmin Hwang et al. THROMBOSIS AND HAEMOSTASIS
- Extended thromboprophylaxis for hip or knee arthroplasty. Does the administration route and dosage regimen affect adherence? A cohort study
- (2019) Juan P. Moreno et al. INTERNATIONAL ORTHOPAEDICS
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Preapproval and postapproval evidence on drugs for multiple sclerosis
- (2018) Chiara Gerardi et al. NEUROLOGY
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Persistence and adherence to the new oral disease-modifying therapies for multiple sclerosis: A population-based study
- (2018) Solmaz Setayeshgar et al. Multiple Sclerosis and Related Disorders
- Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review
- (2018) Ee Ling Yoon et al. Multiple Sclerosis and Related Disorders
- The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
- (2017) Gabriel Pardo et al. JOURNAL OF NEUROLOGY
- Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year
- (2017) Kristen M. Johnson et al. Journal of Managed Care & Specialty Pharmacy
- Factors Associated with Patient Preferences for Disease-Modifying Therapies in Multiple Sclerosis
- (2017) Ana L. Hincapie et al. Journal of Managed Care & Specialty Pharmacy
- The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction
- (2016) Mar Tintoré et al. Patient Preference and Adherence
- An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug
- (2016) Michael Munsell et al. Patient Preference and Adherence
- Adherence to Disease-Modifying Therapies for Multiple Sclerosis
- (2016) Lucas Higuera et al. Journal of Managed Care & Specialty Pharmacy
- Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis
- (2010) Stephanie C. Steinberg et al. CLINICAL DRUG INVESTIGATION
- Persistence and adherence to disease modifying drugs among patients with multiple sclerosis
- (2010) Matthew W. Reynolds et al. CURRENT MEDICAL RESEARCH AND OPINION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation